U. S. Securities and Exchange Commission
                             Washington, D.C. 20549

                                   FORM 10-QSB

(Mark  One)

[X]  QUARTERLY  REPORT  UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
     OF  1934

For the quarter ended January 31, 2002
                      ----------------

[ ]  TRANSITION  REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
     OF  1934

For the transition period from                 to
                               ---------------    --------------------

Commission  File  No.  000-32089
                       ---------

                                 FAR GROUP INC.
                      ------------------------------------
                 (Name of Small Business Issuer in its Charter)

Washington                                                       91-2023071
----------                                                       ----------
(State or Other Jurisdiction of                              (I.R.S.  Employer
incorporation  or  organization)                             Identification No)

                          Suite 210, 580 Hornby Street
                   Vancouver, British Columbia, Canada V6C 3B6
                   -------------------------------------------
                    (Address of Principal Executive Offices)

                                 (604) 662-7000
                          -----------------------------
                            Issuer's Telephone Number

                                      N/A
                                ---------------
          (Former Name or Former Address, if changed since last Report)

Check  whether  the Issuer (1) filed all reports required to be filed by Section
13  or  15(d) of the Exchange Act during the past 12 months (or for such shorter
period  that  the  Company  was required to file such reports), and (2) has been
subject  to  such  filing  requirements  for  the  past  90  days.

      (1)  Yes     X     No        (2)  Yes     X     No
                  ---       ---                ---       ---

     (ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PAST FIVE YEARS)

                                 Not applicable

                     (APPLICABLE ONLY TO CORPORATE ISSUERS)

State the number of shares outstanding of each of the Issuer's classes of common
equity,  as  of  the  latest  practicable  date:

                                  March 5, 2002

        Common - 15,600,000 common shares (after a 6 for 1 forward split)

                       DOCUMENTS INCORPORATED BY REFERENCE

A  description of any "Documents Incorporated by Reference" is contained in Item
6  of  this  Report.

  Transitional Small Business Issuer Format     Yes     X     No
                                                       ---       ---


                                      F-1
<PAGE>
<TABLE>
<CAPTION>
PART  I  -  FINANCIAL  INFORMATION
Item  1.     Financial  Statements.

FAR  Group  Inc.
(A  Development  Stage  Company)
Interim  Balance  Sheet

                                                                               January 31,    April 30,
                                                                                  2002          2001
                                                                                    $             $
                                                                               (unaudited)    (audited)
<S>                                                                           <C>            <C>
ASSETS

Current Asset

Cash                                                                                 5,649        2,361
--------------------------------------------------------------------------------------------------------
Total Assets                                                                         5,649        2,361
========================================================================================================

LIABILITIES AND STOCKHOLDERS' DEFICIT

Current Liabilities

Accounts payable                                                                    32,149        4,199
Accrued liabilities                                                                    475          750
Note payable (Note 4)                                                               35,000       35,000
--------------------------------------------------------------------------------------------------------
Total Liabilities                                                                   67,624       39,949
--------------------------------------------------------------------------------------------------------
Contingency (Note 1)

Stockholders' Deficit

Common Stock: $0.0001 par value; authorized 100,000,000 common shares;
15,600,000 and 2,600,000 shares issued and outstanding respectively (Note 6)         1,560          260

Additional Paid-in Capital                                                          24,440       25,740
--------------------------------------------------------------------------------------------------------
                                                                                    26,000       26,000
--------------------------------------------------------------------------------------------------------
Preferred Stock: $.0001 par value; authorized 20,000,000 preferred shares;
none issued                                                                              -            -
--------------------------------------------------------------------------------------------------------
Deficit Accumulated During the Development Stage                                   (87,975)     (63,588)
--------------------------------------------------------------------------------------------------------
Total Stockholders' Deficit                                                        (61,975)     (37,588)
--------------------------------------------------------------------------------------------------------
Total Liabilities and Stockholders' Deficit                                          5,649        2,361
========================================================================================================
</TABLE>

(See Accompanying Notes to the Interim Financial Statements)



                                      F-2
<PAGE>
<TABLE>
<CAPTION>
FAR  Group  Inc.
(A  Development  Stage  Company)
Interim  Statements  of  Operations
(unaudited)

                                                Accumulated From
                                                 March 24, 2000
                                              (Date of Inception)       Three months ended             Nine months ended
                                                 to January 31,             January 31,                    January 31,
                                                      2002              2002            2001           2002           2001
                                                       $                  $              $              $              $
<S>                                           <C>                     <C>             <C>           <C>             <C>
Revenue                                                     -
-------------------------------------------------------------------------------------------------------------------------------

Expenses

Accounting and legal                                  32,793              (1,035)              -        12,242             500
Bank charges                                             100                   -              25            55              25
Consulting fees                                       15,000               7,500           5,000        10,000           5,000
License written-off                                   35,000                   -               -             -               -
Office                                                   880                 (36)              -           218               -
Transfer agent and filing fees                         4,202                 246           1,303         1,872           1,303
-------------------------------------------------------------------------------------------------------------------------------
Net loss                                             (87,975)             (6,675)         (6,328)      (24,387)         (6,828)
===============================================================================================================================
Net Loss Per Share                                                             -               -             -               -
===============================================================================================================================
Weighted Average Number of Shares
Outstanding (See Note 7 for a six new for
one old forward split applied retroactively)                          15,600,000       9,600,000    15,600,000       9,600,000
===============================================================================================================================
</TABLE>

(Diluted loss per share has not been presented as the result is anti-dilutive)


(See Accompanying Notes to the Interim Financial Statements)


                                      F-3
<PAGE>
<TABLE>
<CAPTION>
FAR  Group  Inc.
(A  Development  Stage  Company)
Interim  Statements  of  Cash  Flows
(unaudited)

                                                   Nine months ended
                                                      January 31,
                                                  2002            2001
                                                    $              $
<S>                                           <C>            <C>
Cash Flows From Operating Activities

Net loss                                           (24,387)         (6,828)

Changes in operating assets and liabilities:

Accounts payable and accrued liabilities            27,675           1,303
---------------------------------------------------------------------------
Net Cash Used by Operating Activities                3,288          (5,525)
---------------------------------------------------------------------------
Cash Flows From Financing Activities

Common shares issued                                     -          10,000

---------------------------------------------------------------------------
                                                         -          10,000
---------------------------------------------------------------------------
Increase In Cash                                     3,288           4,475
Cash at Beginning of Period                          2,361               -
---------------------------------------------------------------------------
Cash at End of Period                                5,649           4,475
===========================================================================

Non-Cash Financing Activities                            -               -
===========================================================================

Supplemental Disclosures

Interest paid                                            -               -
Income tax paid                                          -               -
</TABLE>

(See Accompanying Notes to the Interim Financial Statements)


                                      F-4
<PAGE>
FAR Group, Inc.
A Development Stage Company)
Notes to the Interim Financial Statements
January 31, 2002
(unaudited)


1.   Development  Stage  Company

     FAR  Group,  Inc.  herein  (the "Company") was incorporated in the State of
     Washington,  U.S.A.  on  March  24, 2000. The Company acquired a license to
     market  and  distribute  vitamins,  minerals,  nutritional supplements, and
     other  health  and  fitness  products  in  which the grantor of the license
     offers  these  products  for sale from various suppliers on their Web Site.

     The  Company  is  in the development stage. In a development stage company,
     management  devotes  most  of its activities in developing a market for its
     products.  Planned  principal activities have not yet begun. The ability of
     the  Company  to  emerge  from  the  development  stage with respect to any
     planned  principal  business  activity  is  dependent  upon  its successful
     efforts  to  raise  additional  equity  financing  and/or attain profitable
     operations.  There  is  no guarantee that the Company will be able to raise
     any  equity  financing  or  sell  any of its products at a profit. There is
     substantial  doubt  regarding  the Company's ability to continue as a going
     concern.

     The  Company  filed an SB-2 Registration Statement with the U.S. Securities
     Exchange  Commission  which  was  declared  effective  in January 2001. The
     Company sold and issued 1,000,000 common shares at $0.01 per share for cash
     proceeds  of $10,000. The Company is listed on the OTC Bulletin Board under
     the  symbol  FGRI.


2.   Summary  of  Significant  Accounting  Policies

     (a)  Year  end

          The Company's fiscal year end is April 30.

     (b)  License

          The  cost  to  acquire  the  License  was  initially  capitalized. The
          carrying  value  of the License was evaluated in each reporting period
          to  determine  if  there  were  events  or  circumstances  which would
          indicate  a  possible  inability  to recover the carrying amount. Such
          evaluation  is  based  on  various  analyses  including  assessing the
          Company's  ability  to  bring  the  commercial applications to market,
          related profitability projections and undiscounted cash flows relating
          to  each application which necessarily involves significant management
          judgment.  Where  an  impairment loss has been determined the carrying
          amount  is  written-down  to  fair  market value. Fair market value is
          determined  as  the  amount  at  which  the license could be sold in a
          current  transaction  between  willing  parties.  The  License  was
          written-off  to  operations due to the lack of historical cash flow of
          the  license  and  lack  of  a  market  to  resell  the  license.

     (c)  Cash  and  Cash  Equivalents

          The Company considers all highly liquid instruments with a maturity of
          three  months  or less at the time of issuance to be cash equivalents.

     (d)  Revenue  Recognition

          The  Company will receive from the Grantor of the license, commissions
          of  one-half of all the profit on all sales made through the Grantor's
          Web  Site. The commission revenue will be recognized in the period the
          sales have occurred. The Company will report the commission revenue on
          a  net  basis as the Company is acting as an Agent for the Grantor and
          does not assume any risks or rewards of the ownership of the products.
          This  policy  is  prospective  in  nature  as  the Company has not yet
          generated  any  revenue.


                                      F-5
<PAGE>
2.   Summary  of  Significant  Accounting  Policies

     (e)  Use  of  Estimates

          The  preparation  of financial statements in conformity with generally
          accepted  accounting  principles requires management to make estimates
          and  assumptions  that  affect  the  reported  amounts  of  assets and
          liabilities and disclosure of contingent assets and liabilities at the
          date  of the financial statements and the reported amounts of revenues
          and  expenses  during  the  periods.  Actual results could differ from
          those  estimates.

     (f)  Interim  Financial  Statements

          These interim unaudited financial statements have been prepared on the
          same  basis  as  the annual financial statements and in the opinion of
          management,  reflect  all  adjustments,  which  include  only  normal
          recurring  adjustments,  necessary  to  present  fairly  the Company's
          financial  position,  results  of  operations  and  cash flows for the
          periods  shown.  The  results  of  operations for such periods are not
          necessarily  indicative of the results expected for a full year or for
          any  future  period.


3.   License

     The  Company's  owns  a  license  to market vitamins, minerals, nutritional
     supplements and other health and fitness products through the Grantor's Web
     Site.  The  Company  desires  to  market  these  products  to  medical
     practitioners,  alternative  health professionals, martial arts studios and
     instructors,  sports  and  fitness  trainers,  other  health  and  fitness
     practitioners,  school  and  other  fund raising programs and other similar
     types of customers in Minnesota. The license was acquired on April 13, 2000
     for  a  term of three years. The Company must pay an annual fee of $500 for
     maintenance  of  the Grantor's Web Site commencing on the anniversary date.
     The Grantor waived the annual fee due on April 13, 2001. The Grantor of the
     license  retains  50%  of  the  profits.

     The Company paid total consideration of $35,000 for the license with a note
     payable  of  $35,000.  See  Note  4.

     The  License  was  written-off  to operations due to the lack of historical
     cash  flow  and  lack of a market to resell the license. However, it is the
     Company's intention to conduct a survey to determine its core target market
     from  amongst  the potential clients under its Vitamineralherb.com license,
     hire  commissioned  sales  staff, establish an office, advertise, and begin
     making  sales.


4.   Related  Party  Transactions

     (a)  Transactions

          The  License  referred to in Note 3 was assigned to the Company by the
          sole  director  and  President of the Company for consideration of the
          assumption  of  a note payable of $35,000. The License was recorded at
          the  transferors  cost  of $35,000 which was also fair market value at
          the  time.  The  Grantor of the License is not related to the Company.

     The  $35,000  note  payable  to  the President of the Company is unsecured,
     non-interest  bearing and is repayable upon the successful completion of an
     Initial  Public Offering of the common stock of the Company and sale of all
     registered  shares  pursuant  to  such  offering. As the proceeds from this
     offering are not sufficient to repay this loan the President of the Company
     does  not  intend  to demand repayment until sufficient funds are in place.


                                      F-6
<PAGE>
5.   Commitment

     The  Company  entered into a Business Agreement with Magnum Financial Corp.
     ("Magnum")  whereby  Magnum  was to assist the Company with the approval of
     trading  on  the  OTC  Bulletin  Board.  The  Company  has paid $5,000 upon
     acceptance of this agreement and was to pay $5,000 upon listing for trading
     on the OTC BB and a further $5,000 three weeks after listing for trading on
     the  OTC  BB. This agreement was cancelled and the amount owing was waived.


6.   Common  Stock

     The  Company's Board of Directors approved a six for one forward split with
     a  record  date  of  August  31,  2001.

     A  total  of 15,600,000 common shares are issued and outstanding as at that
     date.


                                      F-7
<PAGE>
Item 2.  Management's Discussion and Analysis or Plan of Operation
------------------------------------------------------------------

The  following  discussion  and  analysis of FAR Group's financial condition and
results  of  operations  should  be  read  in  conjunction  with  the  Financial
Statements  and accompanying notes and the other financial information appearing
elsewhere  in  this  report.

PLAN  OF  OPERATION
-------------------

During  the  period  from  March 24 2000 through January 31, 2002, FAR Group has
engaged  in  no  significant  operations  other  than organizational activities,
acquisition  of  the  rights  to  market  Vitamineralherb  and  preparation  for
registration  of its securities under the Securities Act of 1933, as amended. No
revenues  were  received  by  FAR  Group  during  this  period.

For  the  current  fiscal  year  ending  April  30,  2002, FAR Group anticipates
incurring  a  loss  as a result of expenses associated with setting up a company
structure  to  begin  implementing its business plan. FAR Group anticipates that
until  these  procedures  are  completed, it will not generate revenues, and may
continue  to operate at a loss thereafter, depending upon the performance of the
business.

FAR Group remains in the development stage and, since inception, has experienced
no significant change in liquidity or capital resources or shareholders' equity.
Consequently,  FAR  Group's balance sheet as of January 31, 2002, reflects total
assets  of  $5,649.  The  Company  has  incurred  a loss of $87,975 to date. The
Company  received  $19,861  from a shareholder which was used to pay expenses of
$16,573.  This  resulted  in an increase of cash of $3,288 and a cash balance of
$5,649.  These  advances  are non-interest bearing, unsecured and due on demand.
The  Company  included  in operations legal expenses of $7,993 which represented
due  diligence  costs  spent  on  a possible business acquisition but due to the
uncertainties  in  the  financial  markets as a result of the September 11, 2001
events;  negotiations  were  terminated.

The  original  shareholder  paid  legal expenses upon inception in the amount of
$16,000  for  which he received 1,600,000 shares of common stock of the Company.

The  Company  filed  an  SB-2  Registration  Statement  with the U.S. Securities
Exchange  Commission  which  was declared effective in January 2001. The Company
sold  and issued 1,000,000 common shares at $0.01 per share for cash proceeds of
$10,000.  The  Company  trades  on the OTC Bulletin Board under the symbol FGRI.

FAR  Group's  business  plan  is  to  determine  the  feasibility  of  selling
Vitamineralherb.com  products  to  targeted  markets.  In order to determine the
feasibility of its business plan, FAR Group plans, during the next six to twelve
months,  to conduct research into these various potential target markets. Should
FAR  Group  determine  that the exploitation of the license is feasible, it will
engage  salespeople  to market the products. Based primarily on discussions with
the  licensor,  FAR Group believes that during its first operational quarter, it
will  need  a capital infusion of approximately $85,000 to achieve a sustainable
sales level where ongoing operations can be funded out of revenues. This capital
infusion  is  intended  to  cover  costs  of  advertising, hiring and paying two
salespeople,  and  administrative  expenses.  In  addition,  FAR Group will need
approximately  $260,000  in the event it determines that its market will not pay
in  advance  and  it  will  have to extend credit. FAR Group will have to obtain
additional  financing  through  an  offering or capital contributions by current
shareholders.

FAR  Group  will  need  additional  capital to carry out its business plan or to
engage  in  a  business  combination. No commitments to provide additional funds
have been made by management or other shareholders. Accordingly, there can be no
assurance that any additional funds will be available on terms acceptable to FAR
Group  or  at  all.  FAR  Group  has  no  commitments  for capital expenditures.

In  addition,  FAR  Group may engage in a combination with another business. FAR
Group has engaged in discussions concerning potential business combinations, but
has  not  entered  into  any  agreement  for  such  a  combination.

The  Company's  Board  of  Directors approved a six for one forward split with a
record  date  of August 31, 2001. A total of 15,600,000 common shares are issued
and  outstanding  as  at  that  date.

FAR  Group's  failure  to  generate  revenues  and  conduct operations since its
inception  raise  substantial  doubt  about FAR Group's ability to continue as a
going concern. FAR Group will require substantial working capital, and currently
has  inadequate  capital  to fund its business. FAR Group may be unable to raise
the  funds  necessary  for  implementing its business plan, which could severely
limit  its  operations  and  cause  its  stock  to  be  worthless.


                                      F-8
<PAGE>
PART  II  -  OTHER  INFORMATION

Item 1.  Legal  Proceedings.

         None;  not  applicable.

Item 2.  Changes  in  Securities.

         None;  not  applicable.

Item 3.  Defaults  Upon  Senior  Securities.

         None;  not  applicable.

Item 4.  Submission of Matters to a Vote of Security Holders.

         None;  not  applicable.

Item 5.  Other  Information.

         None;  not  applicable.

Item 6.  Exhibits and Reports on Form 8-K.

         None.


         DOCUMENTS  INCORPORATED  BY  REFERENCE

         None.


                                      F-9
<PAGE>
                                   SIGNATURES

Pursuant  to  the  requirements  of  the  Securities  Exchange  Act of 1934, the
Registrant  has  duly  caused  this  Report  to  be  signed on its behalf by the
undersigned  thereunto  duly  authorized.


                                         FAR  GROUP  INC.


Date:    March 8, 2002                   By:  /s/  Frank  Roberts
       -------------------                    ------------------------------
                                              Frank Roberts, President,
                                              Secretary, Treasurer and
                                              Director


Pursuant to the requirements of the Securities Exchange Act of 1934, as amended,
this  Report  has  been  signed  below by the following persons on behalf of the
Company  and  in  the  capacities  and  on  the  dates  indicated:


                                         FAR  GROUP  INC.


Date:    March 8, 2002                   By:  /s/  Frank  Roberts
       -------------------                    ------------------------------
                                              Frank Roberts, President,
                                              Secretary, Treasurer and
                                              Director


                                      F-10
<PAGE>